CAT No: N1303
CAS No:77739-21-0
Synonyms/Alias:beta-Neoendorphin;77739-21-0;beta-neo-endorphin;Big leu-enkephalin;(2S)-1-[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]acetyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]hexanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]pyrrolidine-2-carboxylic acid;alpha-Neoendorphin, 10-de-L-lysine-;b-Neoendorphin;b-Neo-Endorphin;MFCD00076401;?-NEOENDORPHIN;GTPL1644;SCHEMBL14889478;BDBM82082;HY-P3513;DA-71609;FN109269;MS-31959;CAS_77739-21-0;CB0758529;CS-0615337;Q4897190;
1. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate
2. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
3. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.